732509318	732509318	CD	B-NP	O
|	|	NN	I-NP	O
HH	HH	NN	I-NP	O
|	|	NN	I-NP	O
00531532	00531532	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8792675	8792675	CD	B-NP	O
|	|	CC	I-NP	O
6/27/2006	6/27/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/23/2006	3/23/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
KETTMANN	KETTMANN	NNP	B-NP	O
,	,	,	O	O
QUENTIN	QUENTIN	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
arrest	arrest	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Sepsis/line	Sepsis/line	NN	B-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
54-year-old	54-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
reported	report	VBN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
arrest	arrest	NN	I-NP	O
while	while	IN	B-SBAR	O
receiving	receive	VBG	B-VP	O
dialysis	dialysis	NN	B-NP	O
on	on	IN	B-PP	O
3/25/06	3/25/06	CD	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
clinic	clinic	NN	I-NP	O
at	at	IN	B-PP	O
Richgo	Richgo	NNP	B-NP	O
Ster	Ster	NNP	I-NP	O
Ha	Ha	NNP	I-NP	O
She	She	NNP	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
feel	feel	VB	I-VP	O
nauseated	nauseated	JJ	B-ADJP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
vomited	vomit	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
then	then	RB	B-ADVP	O
reportedly	reportedly	RB	B-ADVP	O
went	go	VBD	B-VP	O
into	into	IN	B-PP	O
VFib	VFib	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
shocked	shock	VBN	I-VP	O
once	once	RB	B-ADVP	O
by	by	IN	B-PP	O
EMS	EMS	NNP	B-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
narrow	narrow	JJ	I-NP	O
QRS	QRS	NN	I-NP	O
complex	complex	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
,	,	,	O	O
received	receive	VBD	B-VP	O
amiodarone	amiodarone	NN	B-NP	O
and	and	CC	I-NP	O
dopamine	dopamine	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
BP	BP	NN	I-NP	O
was	be	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
70s	70	NNS	I-NP	O
systolic	systolic	JJ	B-ADJP	O
over	over	IN	B-PP	O
palpable	palpable	JJ	B-NP	O
diastolic	diastolic	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
portable	portable	JJ	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
opacities	opacity	NNS	I-NP	O
,	,	,	O	O
risk	risk	NN	B-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	I-NP	O
ABG	ABG	NN	I-NP	O
showed	show	VBD	B-VP	O
respiratory	respiratory	JJ	B-NP	O
acidosis	acidosis	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
hospitalized	hospitalize	VBN	I-VP	O
at	at	IN	B-PP	O
Somver	Somver	NNP	B-NP	O
Vasky	Vasky	NNP	I-NP	O
University	University	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
7/1/06	7/1/06	CD	B-NP	O
through	through	IN	B-PP	O
10/11/07	10/11/07	CD	B-NP	O
for	for	IN	B-PP	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
BUN	BUN	NN	I-NP	B-protein
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
had	have	VBD	B-VP	O
risen	rise	VBN	I-VP	O
remarkably	remarkably	RB	B-ADVP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	B-ADJP	O
asymptomatic	asymptomatic	JJ	I-ADJP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
fistulogram	fistulogram	NN	I-NP	O
and	and	CC	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
AV	AV	NN	I-NP	O
fistula	fistula	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
7/6/06	7/6/06	CD	B-NP	O
with	with	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
premedication	premedication	NN	I-NP	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
unsuccessful	unsuccessful	JJ	B-ADJP	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
IJ	IJ	NN	I-NP	O
tunneled	tunnel	VBD	B-VP	O
dialysis	dialysis	NN	B-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
inserted	insert	VBN	I-VP	O
on	on	IN	B-PP	O
1/18/06	1/18/06	CD	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
tip	tip	NN	I-NP	O
ending	end	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
atrium	atrium	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
since	since	IN	I-VP	O
received	receive	VBN	B-NP	O
dialysis	dialysis	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
complication	complication	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
echo	echo	RB	B-ADVP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
of	of	IN	B-PP	O
1999	1999	CD	B-NP	O
shows	show	NNS	I-NP	O
moderate	moderate	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
of	of	IN	B-PP	O
about	about	RB	B-NP	O
65	65	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
20	20	CD	I-NP	O
years	year	NNS	I-NP	O
including	include	VBG	B-PP	O
with	with	IN	B-PP	O
retinopathy	retinopathy	NN	B-NP	O
,	,	,	O	O
nephropathy	nephropathy	NN	B-NP	O
and	and	CC	O	O
neuropathic	neuropathic	JJ	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
20	20	CD	I-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
medullary	medullary	JJ	B-NP	O
CVA	CVA	NNP	I-NP	O
July	July	NNP	I-NP	O
1999	1999	CD	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
PICA	PICA	NNP	I-NP	O
resulting	result	VBG	B-VP	O
Wallenberg	Wallenberg	NNP	B-NP	O
's	's	POS	B-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
knee	knee	NN	B-NP	O
degenerative	degenerative	JJ	I-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
iron-deficiency	iron-deficiency	NN	B-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
gives	give	VBZ	B-VP	O
her	her	PRP	B-NP	O
anaphylaxis	anaphylaxis	NN	I-NP	O
,	,	,	O	O
tetracycline	tetracycline	NN	B-NP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
unknown	unknown	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
include	include	VBP	B-VP	O
amitriptyline	amitriptyline	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
bedtime	bedtime	NN	I-NP	O
,	,	,	O	O
enteric-coated	enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
enalapril	enalapril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Losartan	Losartan	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
Diskus	Diskus	NNP	I-NP	O
250/50	250/50	CD	I-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
inhaler	inhaler	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
50	50	CD	B-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	B-NP	O
subcu	subcu	NN	I-NP	O
and	and	CC	O	O
25	25	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
subcu	subcu	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
lispro	lispro	NN	I-NP	O
18	18	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	B-NP	O
at	at	IN	B-PP	O
dinner	dinner	NN	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
sevelamer	sevelamer	NN	B-NP	O
1200	1200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
tramadol	tramadol	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
single	single	JJ	B-ADJP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
one	one	CD	B-NP	O
son	son	NN	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
grandson	grandson	NN	I-NP	O
.	.	.	O	O

Arturo	Arturo	NNP	B-NP	O
Randklev	Randklev	NNP	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
healthcare	healthcare	NN	I-NP	O
proxy	proxy	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
her	her	PRP$	B-NP	O
son	son	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
worked	work	VBD	B-VP	O
30	30	CD	B-NP	O
years	year	NNS	I-NP	O
for	for	IN	B-PP	O
Wi	Wi	NNP	B-NP	O
Co	Co	NNP	I-NP	O
Baya	Baya	NNP	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
retired	retire	VBN	I-VP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
temperature	temperature	NN	B-NP	O
97.6	97.6	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
72	72	CD	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
of	of	IN	B-PP	O
115/66	115/66	CD	B-NP	O
with	with	IN	B-PP	O
mean	mean	JJ	B-NP	O
arterial	arterial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
83	83	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	NN	B-NP	O
14	14	CD	I-NP	O
,	,	,	O	O
sating	sate	VBG	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
inspired	inspire	VBD	B-VP	O
FiO2	FiO2	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
CVP	CVP	NN	I-NP	B-protein
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
17	17	CD	B-NP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
and	and	CC	O	O
responded	respond	VBD	B-VP	O
to	to	TO	I-VP	O
voice	voice	VB	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pupils	pupil	NNS	I-NP	O
were	be	VBD	B-VP	O
3	3	CD	B-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
mm	mm	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
extraocular	extraocular	JJ	I-NP	O
movements	movement	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
air	air	NN	I-NP	O
movement	movement	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
auscultation	auscultation	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
active	active	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Distal	Distal	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
palpable	palpable	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
thickened	thicken	VBN	I-VP	O
hyperpigmented	hyperpigmented	JJ	B-NP	O
skin	skin	NN	I-NP	O
changes	change	NNS	I-NP	O
on	on	IN	B-PP	O
both	both	DT	B-NP	O
feet	foot	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-NP	O
labs	lab	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
included	include	VBD	B-VP	O
a	a	DT	B-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
141	141	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.1	4.1	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
of	of	IN	B-PP	O
102	102	CD	B-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
of	of	IN	B-PP	O
31	31	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
33	33	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
4.2	4.2	CD	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
glucose	glucose	NN	I-NP	O
of	of	IN	B-PP	O
156	156	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
32	32	CD	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
ABG	ABG	NN	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
on	on	IN	B-PP	O
FiO2	FiO2	NN	B-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
pH	pH	NN	I-NP	O
of	of	IN	B-PP	O
7.36	7.36	CD	B-NP	O
,	,	,	O	O
pCO2	pCO2	NN	B-NP	O
of	of	IN	B-PP	O
52	52	CD	B-NP	O
,	,	,	O	O
pO2	pO2	NN	B-NP	O
91	91	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
first	first	JJ	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzyme	enzyme	NN	I-NP	I-protein
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
of	of	IN	B-PP	O
116	116	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
0.7	0.7	CD	B-NP	O
and	and	CC	O	O
troponin	troponin	NN	B-NP	O
T	T	NN	I-NP	O
of	of	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
and	and	CC	I-NP	O
lactate	lactate	NN	I-NP	O
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

Tox	Tox	NN	B-NP	O
screen	screen	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
was	be	VBD	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
blood	blood	NN	I-NP	O
and	and	CC	O	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
nitrates	nitrate	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
leuks	leuk	NNS	B-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
to	to	TO	I-NP	O
10	10	CD	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
15	15	CD	B-NP	O
to	to	TO	I-NP	O
25	25	CD	I-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
squamous	squamous	JJ	I-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

IMAGING	IMAGING	NN	B-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-NP	O
imaging	imaging	NN	I-NP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
revealing	reveal	VBG	B-VP	O
diffuse	diffuse	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
opacities	opacity	NNS	I-NP	O
,	,	,	O	O
possible	possible	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
versus	versus	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showing	show	VBG	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
100	100	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
old	old	JJ	B-NP	O
T-wave	T-wave	NN	I-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	B-protein
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
55-year-old	55-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
diabetes	diabete	NNS	B-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
VFib	VFib	NN	I-NP	O
arrest	arrest	NN	I-NP	O
at	at	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
on	on	IN	B-PP	O
7/8/06	7/8/06	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
shocked	shock	VBN	I-VP	O
and	and	CC	O	O
admitted	admit	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	O
after	after	IN	B-PP	O
being	be	VBG	B-VP	O
intubated	intubate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Vibay	Vibay	NNP	I-NP	O
General	General	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
difficulty	difficulty	NN	B-NP	O
weaning	wean	VBG	B-VP	O
from	from	IN	B-PP	O
vent	vent	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
finally	finally	RB	I-VP	O
extubated	extubate	VBN	I-VP	O
on	on	IN	B-PP	O
11/11/06	11/11/06	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
CCU	CCU	NN	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
coag-negative	coag-negative	JJ	B-NP	O
Staph	Staph	NN	I-NP	O
grown	grow	VBN	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
Quinton	Quinton	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
blood	blood	NN	I-NP	O
draw	draw	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
wire	wire	NN	I-NP	O
on	on	IN	B-PP	O
11/11/06	11/11/06	CD	B-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
on	on	IN	B-PP	O
10/24/06	10/24/06	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
likely	likely	JJ	B-NP	O
Staph	Staph	NNP	I-NP	O
aureus	aureus	NN	I-NP	O
growth	growth	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
continuous	continuous	JJ	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Question	Question	NN	B-NP	O
of	of	IN	B-PP	O
VFib	VFib	NN	B-NP	O
arrest	arrest	NN	I-NP	O
.	.	.	O	O

Whether	Whether	RB	B-ADVP	O
or	or	CC	O	O
not	not	RB	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
actually	actually	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
VFib	VFib	NNP	I-NP	O
arrest	arrest	NN	I-NP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
doubt	doubt	NN	I-NP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
never	never	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
here	here	RB	B-ADVP	O
by	by	IN	B-PP	O
report	report	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
when	when	WRB	B-ADVP	O
peaked	peak	VBD	B-VP	O
at	at	IN	B-PP	O
0.14	0.14	CD	B-NP	O
on	on	IN	B-PP	O
3/25/06	3/25/06	CD	B-NP	O
after	after	IN	B-PP	O
receiving	receive	VBG	B-VP	O
one	one	CD	B-NP	O
external	external	JJ	I-NP	O
defibrillator	defibrillator	NN	I-NP	O
shock	shock	NN	I-NP	O
at	at	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
believe	believe	VBP	B-VP	O
what	what	WP	B-NP	O
likely	likely	RB	B-VP	O
happened	happen	VBD	I-VP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
vagal	vagal	JJ	I-NP	O
event	event	NN	I-NP	O
during	during	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADVP	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
pause	pause	NN	I-NP	O
misread	misread	NN	I-NP	O
at	at	IN	B-PP	O
VF	VF	NN	B-NP	B-protein
by	by	IN	B-PP	O
the	the	DT	B-NP	O
defibrillator	defibrillator	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
explantation	explantation	NN	I-NP	O
is	be	VBZ	B-VP	O
supported	support	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
observation	observation	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
continuously	continuously	RB	I-VP	O
having	have	VBG	I-VP	O
nausea	nausea	NN	B-NP	O
with	with	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
and	and	CC	O	O
her	her	PRP	B-NP	O
known	know	VBN	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
vasovagal	vasovagal	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NN	B-NP	O
on	on	IN	B-PP	O
3/25/06	3/25/06	NN	B-NP	O
shows	show	VBZ	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
60	60	CD	B-NP	O
to	to	TO	I-NP	O
65	65	CD	I-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
concentric	concentric	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
and	and	CC	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
beta-blocker	beta-blocker	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Volume	Volume	NN	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
close	close	JJ	I-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
gives	give	VBZ	B-VP	O
at	at	IN	B-PP	O
354	354	CD	B-NP	O
pounds	pound	NNS	I-NP	O
by	by	IN	B-PP	O
wet	wet	JJ	B-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
results	result	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Possibly	Possibly	RB	B-NP	O
infected	infected	JJ	I-NP	O
hemodialysis	hemodialysis	NN	I-NP	O
catheter	catheter	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
coag-negative	coag-negative	JJ	B-NP	B-cell_line
Staph	Staph	NN	I-NP	I-cell_line
positive	positive	JJ	I-NP	I-cell_line
blood	blood	NN	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
from	from	IN	B-PP	O
Quinton	Quinton	NNP	B-NP	O
catheter	catheter	NN	I-NP	O
on	on	IN	B-PP	O
11/12/06	11/12/06	CD	B-NP	O
.	.	.	O	O

Line	Line	NN	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
over	over	IN	B-PP	O
wire	wire	NN	B-NP	O
7/28/06	7/28/06	CD	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
dose	dose	NN	I-NP	O
by	by	IN	B-PP	O
renal	renal	JJ	B-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
grow	grow	VB	I-VP	O
out	out	RP	B-PRT	O
coag-negative	coag-negative	JJ	B-NP	O
Staph	Staph	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
from	from	IN	B-PP	O
2	2	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
2	2	CD	I-NP	O
sets	set	NNS	I-NP	O
drawn	draw	VBN	B-VP	O
on	on	IN	B-PP	O
8/30/06	8/30/06	CD	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Anemia	Anemia	NNP	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
end-stage	end-stage	JJ	B-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
is	be	VBZ	B-VP	O
about	about	RB	B-NP	O
30	30	CD	I-NP	O
and	and	CC	I-NP	O
stable	stable	JJ	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Portland	Portland	NNP	I-NP	O
protocol	protocol	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
ICU	ICU	NN	I-NP	O
course	course	NN	I-NP	O
wand	wand	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
and	and	CC	I-NP	O
short-acting	short-acting	JJ	I-NP	B-protein
subcutaneous	subcutaneous	JJ	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
approaching	approach	VBG	B-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	O
BID	BID	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
gradually	gradually	RB	I-VP	O
advanced	advance	VBN	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
oral	oral	JJ	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
extubation	extubation	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
heparin	heparin	NN	B-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
Nexium	Nexium	NN	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Code	Code	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
healthcare	healthcare	NN	I-NP	O
proxy	proxy	NN	I-NP	O
is	be	VBZ	B-VP	O
her	her	PRP$	B-NP	O
son	son	NN	I-NP	O
Noble	Noble	NNP	I-NP	O
Schomberg	Schomberg	NNP	I-NP	O
,	,	,	O	O
284-659-2493	284-659-2493	CD	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
need	need	VB	I-VP	O
rehab	rehab	NN	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
screened	screen	VBN	I-VP	O
by	by	IN	B-PP	O
PT	PT	NN	B-NP	O
and	and	CC	I-NP	O
OT	OT	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
when	when	WRB	B-ADVP	O
bed	bed	NN	B-NP	O
is	be	VBZ	B-VP	O
available	available	JJ	B-ADJP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-7801705	7-7801705	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
ARTOLA	ARTOLA	NNP	B-NP	O
,	,	,	O	O
GARY	GARY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DIX	DIX	NNP	B-NP	O
,	,	,	O	O
REGGIE	REGGIE	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0252108	0252108	VBD	B-VP	O
D	D	NNP	B-NP	O
:	:	:	O	O
1/17/06	1/17/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/17/06	1/17/06	CD	B-NP	O

